Press Releases

Date	Title
10/31/06	AVI BioPharma Discusses Phase II Cardiovascular Clinical Study
10/27/06	AVI BioPharma Publishes Preclinical Data Showing NEUGENE Antisense Inhibition of Multiple Strains of Influenza A Virus
10/19/06	AVI BioPharma Presents Successful Trial Results Using NEUGENE Antisense to Alter Drug Metabolism in Humans
10/18/06	AVI BioPharma Initiates NEUGENE Antisense Clinical Program in Coronary Artery Bypass Grafting
10/4/06	AVI BioPharma Reports Results on Hepatitis C Virus Clinical Trial
9/29/06	AVI BioPharma Presents Positive Preclinical Data Evaluating NEUGENE Antisense Compounds Against Influenza A Virus and the E. coli Bacteria
9/27/06	AVI BioPharma to Present at UBS Global Life Sciences Conference
8/10/06	AVI BioPharma Incorporated 2006 Second Quarter Financial Results Conference Call Transcript
8/9/06	AVI BioPharma Announces Publication of Positive Results from New Class of Antibiotics Using NEUGENE Antisense Technology
8/8/06	AVI BioPharma Reports Second Quarter Financial Results; Conference Call Begins Today at 11:00 a.m. Eastern Time

IR Menu